239 related articles for article (PubMed ID: 10946279)
1. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.
Qian YM; Qin X; Miwa T; Sun X; Halperin JA; Song WC
J Immunol; 2000 Sep; 165(5):2528-34. PubMed ID: 10946279
[TBL] [Abstract][Full Text] [Related]
2. CD59a is the primary regulator of membrane attack complex assembly in the mouse.
Baalasubramanian S; Harris CL; Donev RM; Mizuno M; Omidvar N; Song WC; Morgan BP
J Immunol; 2004 Sep; 173(6):3684-92. PubMed ID: 15356114
[TBL] [Abstract][Full Text] [Related]
3. Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b.
Qin X; Miwa T; Aktas H; Gao M; Lee C; Qian YM; Morton CC; Shahsafaei A; Song WC; Halperin JA
Mamm Genome; 2001 Aug; 12(8):582-9. PubMed ID: 11471050
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in rat CD59 that increase the complement regulatory activity.
Hinchliffe SJ; Morgan BP
Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333
[TBL] [Abstract][Full Text] [Related]
5. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
6. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
7. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
[TBL] [Abstract][Full Text] [Related]
8. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59.
Zhao XJ; Zhao J; Zhou Q; Sims PJ
J Biol Chem; 1998 Apr; 273(17):10665-71. PubMed ID: 9553129
[TBL] [Abstract][Full Text] [Related]
9. The mouse complement regulator CD59b is significantly expressed only in testis and plays roles in sperm acrosome activation and motility.
Donev RM; Sivasankar B; Mizuno M; Morgan BP
Mol Immunol; 2008 Jan; 45(2):534-42. PubMed ID: 17597212
[TBL] [Abstract][Full Text] [Related]
10. Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement.
Zhao J; Rollins SA; Maher SE; Bothwell AL; Sims PJ
J Biol Chem; 1991 Jul; 266(20):13418-22. PubMed ID: 1712784
[TBL] [Abstract][Full Text] [Related]
11. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
Heckl-Ostreicher B; Binder R; Kirschfink M
Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation.
Hinchliffe SJ; Rushmere NK; Hanna SM; Morgan BP
J Immunol; 1998 Apr; 160(8):3924-32. PubMed ID: 9558099
[TBL] [Abstract][Full Text] [Related]
13. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.
Meri S; Lehto T; Sutton CW; Tyynelä J; Baumann M
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):923-35. PubMed ID: 8670172
[TBL] [Abstract][Full Text] [Related]
14. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.
Ratnoff WD; Knez JJ; Prince GM; Okada H; Lachmann PJ; Medof ME
Clin Exp Immunol; 1992 Mar; 87(3):415-21. PubMed ID: 1371955
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
16. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59.
Powell MB; Marchbank KJ; Rushmere NK; van den Berg CW; Morgan BP
J Immunol; 1997 Feb; 158(4):1692-702. PubMed ID: 9029105
[TBL] [Abstract][Full Text] [Related]
19. Structure/function characterization of porcine CD59: expression, chromosomal mapping, complement-inhibition, and costimulatory activity.
Maher SE; Pflugh DL; Larsen NJ; Rothschild MF; Bothwell AL
Transplantation; 1998 Oct; 66(8):1094-100. PubMed ID: 9808497
[TBL] [Abstract][Full Text] [Related]
20. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
